Enno Spillner interviewed at the Equity Forum in Frankfurt
(in German only)
At the Equity Forum in Frankfurt on November 24, CFO Enno Spillner spoke with Börsen Radio Network AG about Formycon’s current Q3 results. He emphasized that the company remains confident that it will become profitable by 2027.
At the same time, he emphasized that Formycon remains committed to its mission: to reduce healthcare costs and give patients access to affordable therapies.
Tune in and enjoy the full interview!